199 related articles for article (PubMed ID: 1844232)
1. Skin manifestation of extramedullary relapse in adult with acute lymphoblastic leukaemia.
Rudzka E; Holowiecki J; Kachel L; Lawniczek T; Pajak J
Haematologia (Budap); 1991; 24(4):235-9. PubMed ID: 1844232
[TBL] [Abstract][Full Text] [Related]
2. Acute myelofibrosis terminating in acute lymphoblastic leukemia: case report and review of the literature.
Dunphy CH; Kitchen S; Saravia O; Velasquez WS
Am J Hematol; 1996 Jan; 51(1):85-9. PubMed ID: 8571944
[TBL] [Abstract][Full Text] [Related]
3. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
Sancho JM; Ribera JM; Xicoy B; Morgades M; Oriol A; Tormo M; del Potro E; Debén G; Abella E; Bethencourt C; Ortín X; Brunet S; Ortega-Rivas F; Novo A; López R; Hernández-Rivas JM; Sanz MA; Feliu E;
Eur J Haematol; 2007 Feb; 78(2):102-10. PubMed ID: 17087744
[TBL] [Abstract][Full Text] [Related]
4. Long-term results of AIEOP-8805 protocol for acute B-cell lymphoblastic leukemia of childhood.
Pillon M; Aricò M; Basso G; Locatelli F; Citterio M; Micalizzi C; Testi AM; Barisone E; Nardi M; Lombardi A; Rondelli R; Rosolen A;
Pediatr Blood Cancer; 2011 Apr; 56(4):544-50. PubMed ID: 21298738
[TBL] [Abstract][Full Text] [Related]
5. Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica.
Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi A; Miniero R; Di Tullio MT; Lo Nigro L; Pession A; Rondelli R; Messina C; Santoro N; Mori PG; De Rossi G; Tamaro P; Silvestri D; Biondi A; Basso G; Masera G
Haematologica; 1998 Sep; 83(9):791-9. PubMed ID: 9825576
[TBL] [Abstract][Full Text] [Related]
6. Infusion of anti-CD10 monoclonal antibody (J5) following ablative chemotherapy in a patient with refractory pre-B acute lymphoblastic leukemia.
Ruiz-Argüelles GJ; Ruiz-Argüelles A; Lobato-Mendizábal E; Presno-Bernal M; Alvarez-Amaya C
Rev Invest Clin; 1991; 43(3):259-63. PubMed ID: 1840161
[TBL] [Abstract][Full Text] [Related]
7. B-lineage acute lymphoblastic leukemia of childhood. An institutional experience.
Rivera-Luna R; Cardenas-Cardos R; Leal-Leal C; Navarro-Alegría I; Meza-Coria C; Gómez-Martínez R; Vega-Vega L
Arch Med Res; 1997; 28(2):233-9. PubMed ID: 9204615
[TBL] [Abstract][Full Text] [Related]
8. [Investigations in the use of mogramostime (GM-CSF) in patients with acute leukemia].
Paśnicki M
Wiad Lek; 1995; 48(1-12):194-7. PubMed ID: 9638239
[No Abstract] [Full Text] [Related]
9. Acute lymphoblastic leukemia in a patient with chronic cyanoacrylate exposure.
Layden BT; Joseph M; Tallman MS; Platanias LC
Acta Haematol; 2007; 118(4):242-3. PubMed ID: 18087146
[TBL] [Abstract][Full Text] [Related]
10. Follow-up of the first two successive German multicentre trials for adult ALL (01/81 and 02/84). German Adult ALL Study Group.
Hoelzer D; Thiel E; Ludwig WD; Löffler H; Büchner T; Freund M; Heil G; Hiddemann W; Maschmeyer G; Völkers B
Leukemia; 1993 Aug; 7 Suppl 2():S130-4. PubMed ID: 8361217
[No Abstract] [Full Text] [Related]
11. Parenchymal brain leukemia. Case report: problems related to the diagnosis and treatment.
Corbetta A; Jankovic M; Conter V; Fuga T; Crivellaro M; Masera G
Haematologica; 1991; 76(4):324-6. PubMed ID: 1794739
[TBL] [Abstract][Full Text] [Related]
12. Persistence of peripheral blood and bone marrow blasts during remission induction in adult acute lymphoblastic leukemia confers a poor prognosis depending on treatment intensity.
Cortes J; Fayad L; O'Brien S; Keating M; Kantarjian H
Clin Cancer Res; 1999 Sep; 5(9):2491-7. PubMed ID: 10499624
[TBL] [Abstract][Full Text] [Related]
13. Childhood acute lymphoblastic leukaemia: outcomes of 54 consecutive patients treated in Auckland 1985-1991.
Mauger DC; Skeen JE
N Z Med J; 1998 Nov; 111(1078):454-6. PubMed ID: 9891565
[TBL] [Abstract][Full Text] [Related]
14. [Preliminary evaluation of the treatment of recurrences of acute lymphoblastic leukemia by the BFM (Henze) method].
Ochocka M; Zelenay E
Pediatr Pol; 1988 Nov; 63(11):716-22. PubMed ID: 3253658
[No Abstract] [Full Text] [Related]
15. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
[TBL] [Abstract][Full Text] [Related]
16. Alternating pulses of vincristine-prednisone with cytarabine-cyclophosphamide versus vincristine-prednisone in the maintenance therapy of acute lymphoblastic leukemia.
Sackmann Muriel F; Svarch E; Pavlovsky S; Bustelo P; Giuntoli J; Vergara B; Garay G; Eppinger-Helft M; Kvicala R; Dibar E
Cancer Treat Rep; 1984 Apr; 68(4):581-6. PubMed ID: 6370428
[TBL] [Abstract][Full Text] [Related]
17. Treatment of acute lymphoblastic leukaemia (ALL).
Jacobs P; Wood L
Eur J Haematol; 1992 Aug; 49(2):53-8. PubMed ID: 1397240
[TBL] [Abstract][Full Text] [Related]
18. [Plasmacytoid dendritic cell tumor].
Pérez-Crespo M; Moragón M; Onrubia J; Sevila A; Alfonso R; Miralles J; Requena L
Actas Dermosifiliogr; 2011 Apr; 102(3):229-31. PubMed ID: 21232729
[No Abstract] [Full Text] [Related]
19. [Late recurrence (11 years) in a case of ALL. Recurrence or a second disease?].
García Zueco JC; Torres Gómez M; López Gómez L; Martín Guerrero Y
Sangre (Barc); 1992 Apr; 37(2):152-3. PubMed ID: 1621188
[No Abstract] [Full Text] [Related]
20. Complete paraplegia after nelarabine treatment in a T-cell acute lymphoblastic leukemia adult patient.
Papayannidis C; Iacobucci I; Abbenante MC; Curti A; Paolini S; Parisi S; Baccarani M; Martinelli G
Am J Hematol; 2010 Aug; 85(8):608. PubMed ID: 20658590
[No Abstract] [Full Text] [Related]
[Next] [New Search]